Search
1 - 15 of 15 items
Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors
133-139
Abstract : 1244
PDF : 511
Survival Analysis of Lung Adenocarcinoma Patients with Exon 19 Del and 21 L858R Mutations Receiving EGFR-TKI Treatment
101-107
Abstract : 549
PDF : 429
The Effect of Anemia on Prognostic in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
120-129
Abstract : 476
PDF : 267
Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer
140-146
Abstract : 150
PDF : 57
Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?
64-71
Abstract : 744
PDF : 576
The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
22-30
Abstract : 507
PDF : 222
The Role of Thromboelastography in Heparin Therapy for COVID-19 Patients
119-125
Abstract : 654
PDF : 299
Giant Cell Lung Carcinoma: A Case Report of a Rare Histology Type of Non-Small Cell Lung Cancer
143-148
Abstract : 545
PDF : 300
Problem Terapeutik pada Empiema Terlokulasi karena Tuberkulosis [Theurapetic Problem in Tuberculosis Loculated Empyema]
86-93
Abstract : 1456
PDF : 5488
1 - 15 of 15 items